Ranolazine Tablet, Film Coated, Extended Release
Product Images NDC 71335-2556

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ranolazine (NDC 71335-2556). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemicalstructure (Chemicalstructure)

Chemical structure diagram of ranolazine, showing the arrangement of atoms and bonds representing its molecular framework.*

FDA Label Image

Label (Lbl713352556)

Label for Ranolazine Extended-Release Tablets, 500 mg strength, containing 60 film-coated extended-release oral tablets. The label includes the NDC number 71335-2556-1 and indicates repackaging by Bryant Ranch Prepack, with manufacturing by i3 Pharmaceuticals, LLC. It also notes storage instructions, child-resistant packaging, and a QR code for package insert information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.